文献速递眼底病与葡萄膜炎

糖尿病视网膜病变严重程度与未来脑血管病、心血管病及全因死亡风险

Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
PubMed 文献 · Ophthalmology · 2020-12-25

PURPOSE: To determine the relationship between the severity of diabetic retinopathy and the future risk of cerebrovascular accident (CVA), myocardial infarction (MI), congestive heart failure (CHF), and all-cause mortality in patients with type 2 diabetes mellitus.…

要点

  • 轻度非增殖期糖尿病视网膜病变已与脑血管意外、心肌梗死、心力衰竭及死亡风险升高相关。
  • 中重度非增殖期及增殖期糖尿病视网膜病变患者各结局风险进一步升高。
  • 视网膜信息可能为评估患者未来血管疾病和死亡风险提供有价值线索。

核心结论

  • 糖尿病视网膜病变与未来脑血管意外、心肌梗死、充血性心力衰竭及死亡风险显著相关,且病变程度越高风险越高。

主要发现

  • 与无视网膜病变患者相比,轻度非增殖期糖尿病视网膜病变患者脑血管意外风险HR为1.31(95%CI 1.18-1.46),心肌梗死HR为1.30(95%CI 1.15-1.46),充血性心力衰竭HR为1.29(95%CI 1.19-1.40),死亡HR为1.15(95%CI 1.05-1.25)。
  • 中重度非增殖期糖尿病视网膜病变患者脑血管意外风险HR为1.56(95%CI 1.29-1.89),心肌梗死HR为1.92(95%CI 1.57-2.34),充血性心力衰竭HR为1.90(95%CI 1.66-2.18),死亡HR为1.55(95%CI 1.32-1.82)。
  • 增殖期糖尿病视网膜病变患者脑血管意外风险HR为2.53(95%CI 1.84-3.48),心肌梗死HR为1.89(95%CI 1.26-2.83),充血性心力衰竭HR为1.96(95%CI 1.47-2.59),死亡HR为1.87(95%CI 1.36-2.56)。

临床怎么用

  • 在糖尿病视网膜病变筛查中,可根据视网膜病变严重程度识别未来血管疾病和死亡高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the relationship between the severity of diabetic retinopathy and the future risk of cerebrovascular accident (CVA), myocardial infarction (MI), congestive heart failure (CHF), and all-cause mortality in patients with type 2 diabetes mellitus. DESIGN: Retrospective cohort study. PARTICIPANTS: Patients with type 2 diabetes who underwent diabetic retinopathy screening via fundus photography. METHODS: The relationship between retinopathy status and the 5-year risk of first-time CVA, MI, CHF, and all-cause mortality was investigated using multivariate Cox proportional hazards regressions that controlled for age, gender, race or ethnicity, hemoglobin A1c, duration of diabetes, high-density lipoprotein level, low-density lipoprotein level, history of hypertension, systolic blood pressure, diastolic blood pressure, tobacco use, statin use, body mass index, urine microalbumin-to-creatinine ratio, and estimated glomerular filtration rate. MAIN OUTCOME MEASURES: Five-year risk of first-time CVA, MI, CHF, and all-cause mortality. RESULTS: Seventy-seven thousand three hundred seventy-six patients were included in this study. The average age was 59.8 years with 53.6% male, 31.2% non-Hispanic White, and 41.4% Hispanic patients. Diabetic retinopathy was significantly associated with all outcomes on multivariate analysis. Compared with patients with no retinopathy, those with minimal nonproliferative diabetic retinopathy (NPDR) had a higher risk of CVA (hazard ratio [HR], 1.31; 95% confidence interval [CI], 1.18-1.46), MI (HR, 1.30; 95% CI, 1.15-1.46), CHF (HR, 1.29; 95% CI, 1.19-1.40), and death (HR, 1.15; 95% CI, 1.05-1.25). Similarly, patients with moderate to severe NPDR had a higher risk of each outcome (CVA: HR, 1.56; 95% CI, 1.29-1.89; MI: HR, 1.92; 95% CI, 1.57-2.34; CHF: HR, 1.90; 95% CI, 1.66-2.18, and death: HR, 1.55; 95% CI, 1.32-1.82), as did patients with proliferative diabetic retinopathy (CVA: HR, 2.53; 95% CI, 1.84-3.48; MI: HR, 1.89; 95% CI, 1.26-2.83; CHF: HR, 1.96; 95% CI, 1.47-2.59; and death: HR, 1.87; 95% CI, 1.36-2.56). CONCLUSIONS: Diabetic retinopathy is significantly associated with future risk of CVA, MI, CHF, and death, with higher degrees of retinopathy appearing to carry a heightened risk for each outcome. Retinal information may provide valuable insights into patients' risk of future vascular disease and death.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Modjtahedi BS, Wu J, Luong TQ, et al. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality. Ophthalmology. 2020. PMID: 33359888. doi:10.1016/j.ophtha.2020.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。